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Abstract
A 61 year old man presented with diffuse large B cell lymphoma of the skin of the back of the
shoulder which was excised and treated with chemotherapy (CHOP regime) in 1998. He was in
complete remission till he presented in 2002 with extranodal marginal zone lymphoma of the
parotid gland for which he underwent superficial parotidectomy and radiotherapy. He continued in
remission till 2006 when he presented with recurrent pericardial effusion and tamponade. At
median sternotomy, pericardial effusion was drained, an anterior pericardiectomy was done and a
left posterior pericardial window made, and an enlarged hard paraaortic lymph node excised.
Histology, immunocytochemistry and chromosome analysis revealed Burkitt lymphoma. Patient
underwent chemotherapy with CODOX-M regime and continues in remission. This report is
unusual on account of the highly atypical presentation of Burkitt lymphoma as cardiac tamponade,
only a few cases having been reported previously, the occurrence of three lymphomas of different
pathological and genomic profiles in one patient over a period of eight years and the relatively slow
rate of growth of an otherwise fulminant tumour with high tumour doubling time. A review of
literature with special emphasis on chromosomal diagnosis, transformation of other lymphomas
into Burkitt lymphoma and mediastinal and cardiac involvement with Burkitt lymphoma is
presented.
Background
Burkitt lymphoma is a type of B cell Non Hodgkin lym-
phoma which has endemic (African) and non-endemic
(American) sub-divisions. An aggressive tumour involv-
ing mostly abdomen, jaw, head, neck and peripheral
lymph node sites, it has a tumour doubling time of only
24 hrs. Involvement of mediastinal lymph nodes is
extremely rare and there are only isolated instances of
presentation with cardiac tamponade. To our knowledge,
there are no reports of a delayed transformation of a large
diffuse B cell lymphoma or a marginal zone parotid lym-
phoma into a Burkitt lymphoma after a long period of
remission.
Case Presentation
A 61 year old male underwent excision of diffuse large B
cell lymphoma of the skin over left shoulder in 1998
which was treated with CHOP chemotherapy including
Prednisolone. He stayed in remission till 2002 when he
presented with a painless swelling of the preauricular
region arising from the parotid gland for which he under-
went superficial parotidectomy. The histology revealed
extra-nodal marginal zone lymphoma of parotid salivary
gland. The immunohistochemistry revealed a composite
phenotype: CD20+, CD5-, CD10-, bcl 6-, bcl 1-, bcl 2+,
bcl 10-, p53+/-, p21+/-, CD79a+. There was no evidence
of the previous diffuse large B cell lymphoma. Radiother-
apy was given to left parotid area over 3 weeks in 15 frac-
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till May 2006 when he presented with 5 week history of
exertional shortness of breath, easy fatigability, lethargy,
headache, agitation, poor appetite and erratic blood glu-
cose.
Other significant past history included IDDM, hyperten-
sion, hypothyroidism following radioactive iodine ther-
apy for thyrotoxicosis, peripheral neuropathy, chronic
asthma, previous anterolateral and inferior myocardial
infarctions and excision of basal cell carcinoma from back
and right temple in 1998 and 2002 respectively.
Examination, on presentation in May 2006, revealed heart
rate of 78 beats per minute, irregular, BP 95/70, 95% sat-
urations on room air, raised JVP, soft bilateral thyromeg-
aly and unremarkable cardiac and respiratory
examinations.
Routine blood examination was normal except for ESR
which was raised at 84/min and abnormal thyroid func-
tion tests. ECG confirmed atrial fibrillation, evidence of
old inferior infarct and low voltage complexes. Chest X-
ray revealed an enlarged globular cardiac silhouette (Fig
1). Transthoracic echocardiography demonstrated a glo-
bal 5 cm pericardial effusion with evidence of diastolic
right ventricular collapse and impaired right and left ven-
tricular function. Percutaneous drainage of the effusion
was performed using an indwelling pigtail catheter intro-
duced subcostally and the fluid sent for cytological and
microbiological analysis. Cytology was negative for malig-
nant cells and microbiology showed no bacterial growth.
Meanwhile, repeat echocardiography showed rapid reac-
cumulation of pericardial effusion despite the presence of
the indwelling catheter. Contrast CT scan of thorax, abdo-
men and pelvis confirmed massive pericardial effusion
(Fig 2) and an enlarged paraaortic lymph node (Fig 3).
Patient was transferred to our tertiary cardiac surgical cen-
tre for further management. A coronary angiogram
revealed a chronically occluded right coronary artery and
minor disease in left coronary system. A left ventriculo-
gram demonstrated inferior and basal akinesia with good
function elsewhere.
Patient underwent transoesophageal echocardiogram in
theatre which confirmed right heart collapse in diastole
associated with large pericardial effusion. A median ster-
notomy was made in preference to video assisted thoraco-
scopic procedure, recognising the need for possible
resuscitation in view of the fragile haemodynamic state of
the patient. Another reason to prefer median sternotomy
was the presence of concomitant coronary artery disease
and ventricular dysfunction which may have required
concomitant surgical revascularisation. Operative find-
ings included a tense pericardial cavity filled with 750 mls
of serosanguineous fluid with fibrinous exudates, 3 cm ×
2 cm paraaortic lymph node of hard consistency, adherent
to the right lateral surface of ascending aorta, below the
innominate artery and a diffusely inflamed pericardium.
A generous anterior pericardiectomy from great vessels to
diaphragm vertically and phrenic nerve to phrenic nerve
horizontally was done and a left posterior pericardial win-
dow made into the left pleural cavity posterior to the left
phrenic nerve. The clearly abnormal, hard and adherent
paraaortic lymph node was excised and pericardial fluid
evacuated. Pleurae were widely opened and the pleural
cavities drained. The thymus, preaortic lymph node and
CT scan of chest showing large pericardial effusionFigure 2
CT scan of chest showing large pericardial effusion.
Chest X-ray showing widened cardiac silhouette suggestive of large pericardial effusionFigur 1
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portion of lymph node for haematological malignancy
assay including flow, immunohistochemistry, FISH and
morphology, and pericardial fluid for cytology and micro-
biology.
Microbiology of the pericardial fluid was negative for bac-
terial and mycobacterial growth. Cytology of pericardial
fluid was that of a highly cellular fluid containing erythro-
cytes, small lymphocytes, mesothelial cells, macrophages
and, significantly, a minority population of large lym-
phoid cells (LCA positive). Histopathology of thymus was
normal. Pericardium showed active chronic inflamma-
tion with focal florid mesothelial cell reaction, considered
to be reactive in nature. Histopathology of the lymph
node demonstrated complete effacement of the normal
architecture by large population of highly proliferative
monomorphic moulded angular neoplastic lymphoid
cells with clumped chromatin and small nucleoli and
large pale macrophages forming the "stars" in the "starry
sky" typical of but not unique to Burkitt Lymphoma (Fig
4).
Flow cytometry showed: B-cell LPD. B cells = 51.6% of
leukocytes, composite phenotype. CD5-
CD20+CD38+CD10-CD22+FMC7+CD23-Lamda-Kappa-
IgM-D-G+/-CD79b- CD52+. Immunohistochemistry
results revealed: CD10+ Mib-1 100% bcl-2- p53 deregulated bcl-
6+ FOX-P1-. FISH results: BCL-2/IgH: deletion; alpha18:
normal; c-MYC: rearranged; alpha 8: normal; BCL-6: nor-
mal; p53: normal; alpha 17: normal; IgH: normal; BCL-2:
deletion. Thus interphase FISH showed cMYC rearrange-
ment in the majority of cells which confirmed the diagno-
sis of Burkitt lymphoma (Fig 5, 6 and 7).
Patient's postoperative course was uneventful and he was
discharged home 9 days after surgery. He is currently in
remission.
Discussion
Histologically, Burkitt lymphoma (BL) falls in the cate-
gory of small noncleaved cell high grade Non-Hodgkin
lymphoma [1]. It can be divided into two distinct types
which are histologically identical but have important clin-
ical and virological differences. The African endemic form
presents as a jaw tumour that spreads to extra-nodal sites,
particularly bone marrow and meninges. The American
form presents with abdominal disease and ascites and
also spreads to bone marrow and meninges [2]. There is
an increasing incidence of both types with acquired
immunedeficiency states like HIV [3] and, rarely, follow-
ing immunosuppression after transplantation [4]. Our
patient presented with a highly unusual mediastinal
lymph node involvement and secondary pericardial effu-
sion and tamponade. He had presented 8 years ago with
Diffuse large B cell lymphoma of the skin of the back of
the shoulder and 4 years thereafter with Marginal zone
lymphoma of the parotid with surprisingly prolonged
periods of remission after each presentation.
Sporadic, endemic and HIV associated BL are all charac-
terized by chromosomal rearrangements involving c-myc
proto-oncogene that lead to its inappropriate expression.
C-myc proto-oncogene plays a central role in fundamental
aspects of cell biology and proliferation, differentiation,
metabolism, apoptosis and telomere maintenance [5]. BL
cells carry a balanced translocation involving the c-myc
locus on chromosome 8 and band 32 of chromosome 14
Biopsy of  preaortic lymph node showing monomorphic m ulded neoplastic ly phoid c lls with large pale macro-phage "stars".F g r  4
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chain (Cμ), which subjects it to relentless stimulation by
the enhancer element of the immunoglobulin gene. Alter-
nately, the translocation causes mutations in the regula-
tory sequences of the myc gene, the coding sequences of
the gene remaining always intact [6]. Rarely, translocation
involves chromosomes 2 and 22 instead of chromosome
14[6]. The specific breakpoint locus differs between vari-
ous forms of BL, there being a definite relation between
the level of myc overexpression in BL and genomic break-
point location within the myc locus [7], Halembiena et al
having identified translocation breakpoints at 190 kb 5'
and 50 kb 3' of myc [8]. Based on a study of surface immu-
noglobulins in 91 biopsy samples, Gunven suggested only
one cell clone was involved in BL in the majority of cases
[9]. However, novel sporadic BL cell lines (BLUE-1) with
a unique t (6; 20) (q15; q11.2) rearrangement in addition
to the usual pathognomonic t (8;14)(q24;q32) transloca-
tion has been described [10]. Secondary chromosomal
abnormalities have been studied to predict outcome in
BL, and abnormalities of chromosome 13(13 q) and
22(22 q) had a negative impact on prognosis [11].
Trisomy12 has been described with Burkitt lymphoma
[12]. Hummel et al used transcriptional and genomic pro-
filing to generate a molecular signature for BL and identi-
fied 58 genes that constituted the molecular BL [13].
Our patient had c-myc rearrangement in the majority of
cells which confirmed the diagnosis of Burkitt lymphoma.
There was loss of one copy of BCL-2, the significance of
which is unknown.
Histologically, BL consists of a sea of strikingly monoto-
nous cells with a characteristically high mitotic index and
cell death, accounting for the presence of numerous tissue
macrophages with ingested nuclear debris, often sur-
rounded by a clear space, creating a "starry sky" pattern
[1]. Our patient showed complete effacement of lymph
node architecture by moderate to large lymphoid cells
with prominent nucleoli.
FISH showing IgH region not rearrangedigure 7
FISH showing IgH region not rearranged.
FISH showing IgL region not rearrangedigure 5
FISH showing IgL region not rearranged.
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vated germinal centre B cells and express IgM, pan B cell
markers like CD 19, CD 20, CD24, 1a, as well as CD10.
The African cases are CD 21 positive and most sporadic
cases are CD negative. Mutations of p53 gene lead to accu-
mulation of mutant protein within tumour cells which
can be detected on paraffin-embedded tissues [14]. There
was p53 deregulation in our patient, with CD 10+, Mib-1
(100%), bcl-2 (neg), FOX-P1 (neg).
Differentiation between Diffuse large B cell lymphoma
(DLBCL) and BL is of crucial importance since prognosis
and treatment differ. Nakamura et al differentiated
between BL and DLBCL with c-mycR and identified the
following criteria for BL: growth fraction of nearly 100%,
monotonous proliferation of medium sized cells and
CD10+, bcl 2- and low frequency of mutation of VH genes
[15]. Cogliatti et al set the following criteria for differenti-
ation: a mature B cell phenotype of CD 10+, bcl 6+, bcl 2-
, a proliferation rate greater than 95% and c-myc rear-
rangements in the absence of t(14;18)(q32;q21) [16].
Dave et al, using gene expression profiling suggested the
following criteria: high level of expression of c-myc target
genes, expression of a subgroup of germinal centre B cell
genes, low level of expression of major MHC-class 1 genes
and nuclear factor Kappa B target genes [17]. WHO crite-
ria for BL include classical/atypical histology, CD20+, bcl
6+, CD 10+, BCL2-, CD 5-, Ki 67 score =/>95% and IG –
myc+ [13]. Our patient met all the above criteria in sup-
port of BL.
Transformation of histologically and genetically different
lymphomas into BL has been anecdotally reported.
Mukhopadyay et al reported the extremely rare transfor-
mation of a follicular lymphoma into a Burkitt-like lym-
phoma in a single lymph node illustrating the unusual
oncogenic stimulus that resulted from inhibition of apop-
tosis of bcl-2 combined with deregulation of cell growth
by c-myc [18]. Raghoebier reported the histological con-
version of follicular lymphoma into BL with extensive
alterations within both the functional IG heavy chain
allele and around the t (14; 18) breakpoint, indicating
clonal evolution rather than the appearance of an inde-
pendent lymphoma [19]. Tomita reported atypical BL
arising from follicular lymphoma, inguinal lymph node
biopsy having shown composite lymphoma and chromo-
somal analysis of marrow having revealed t (8; 14) and t
(14; 18) in identical cells. The patient died after 4 months
despite chemotherapy [20]. HeIntel et al reported BL in a
patient with previous splenic marginal zone lymphoma
with IgH sequence showing no identity between the two
clones [21]. Our patient, to the best of our knowledge, is
the first patient in world literature to have had 3 histolog-
ically different lymphomas over a period of 8 years, start-
ing with Diffuse large B cell lymphoma of the skin over
the back of shoulder in 1998, followed by Marginal zone
lymphoma of the left parotid in 2002 followed by Burkitt
lymphoma in 2006.
There have been isolated reports of Burkitt lymphoma of
heart, pericardium or mediastinum. Singh et al reported
AIDS-related BL of the heart presenting with acute right
heart failure with fatal secondary pulmonary hyperten-
sion [22]. Fatimi et al reported intracardiac BL mimicking
acute pulmonary embolism [23]. Bergler-Klein et al
reported the case of young woman with generalised BL
presenting with myocardial infiltration mimicking
HOCM which resolved with high intensity chemotherapy
with modified B-ALL protocol [24]. Hoffmeier described
complete remission of intracardiac BL in an 85 year old
man treated with 6 courses of CHOP regime [25]. Ike-
matsu et al reported a 26 year old woman with abdominal
BL requiring laparotomy, presenting with cardiac tam-
ponade due to pericardial infiltration treated successfully
with drainage, doxycycline, 7 courses of chemotherapy
and CNS prophylaxis [26]. Chalabreysee [27] and Gra-
ham [28] reported BL presenting with pericardial effu-
sion. In a large series of 92 patients of BL reported by
Kemeny, 5 patients developed pericardial effusion [29].
Helfland reported cardiac tamponade caused by BL infil-
trating pericardium and heart in a homosexual man [30].
Our patient presented with a large bloody pericardial effu-
sion with tamponade and had para-aortic lymph node
involvement. Pericardium was grossly inflamed but there
was no infiltration with lymphoma.
To conclude, Burkitt lymphoma may present exception-
ally with recurrent pericardial effusion or tamponade.
Treatment should be aggressive and optimistic and a sig-
nificant number of patients respond favourably to treat-
ment.
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